Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function.
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.]
Moving to Fingolimod From Natalizumab in Multiple Sclerosis: The ENIGM Is Not Solved.
Alemtuzumab for multiple sclerosis: a new age of immunotherapy.
Brain Metabolite Changes in Subcortical Regions After Exposure to Cuprizone for 6 Weeks: Potential Implications for Schizophrenia.
[Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : A review.]
Risk factors for increased multiple sclerosis susceptibility in the Iranian population.
Influence of Peripheral inflammation on the progression of Multiple Sclerosis: Evidence from the clinic and experimental animal models.
Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.
Paradoxical inflammation induced by anti-TNF agents in patients with IBD.
Microsatellite polymorphism in haem oxygenase 1 gene promoter in multiple sclerosis.
Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study.
[Kidney function tests in multiple sclerosis].
A mechanism-based classification of pain in multiple sclerosis.
Linkage of multiple sclerosis and guillain-barre syndrome: a population-based survey in isfahan, iran.
Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.
Editorial comment.
The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS.
Images in clinical medicine. Bilateral internuclear ophthalmoplegia in multiple sclerosis.
Gait and six-minute walk performance in persons with multiple sclerosis.
FDA warns about the risks of unproven surgical therapy for multiple sclerosis.
Early netrin-1 expression impairs central nervous system remyelination.
Elevated HSP27 levels during attacks in patients with multiple sclerosis.
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.
Pages
« first
‹ previous
…
297
298
299
300
301
302
303
304
305
…
next ›
last »